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Abstract
Synaptic function and plasticity are crucial for information processing within the nervous system. In glutamatergic
hippocampal neurons, presynaptic function is silenced, or muted, after strong or prolonged depolarization. This muting is
neuroprotective, but the underlying mechanisms responsible for muting and its reversal, unmuting, remain to be clarified.
Using cultured rat hippocampal neurons, we found that muting induction did not require protein synthesis; however, slow
forms of unmuting that depend on protein kinase A (PKA), including reversal of depolarization-induced muting and
forskolin-induced unmuting of basally mute synapses, required protein synthesis. In contrast, fast unmuting of basally mute
synapses by phorbol esters was protein synthesis-independent. Further studies of recovery from depolarization-induced
muting revealed that protein levels of Rim1 and Munc13-1, which mediate vesicle priming, correlated with the functional
status of presynaptic terminals. Additionally, this form of unmuting was prevented by both transcription and translation
inhibitors, so proteins are likely synthesized de novo after removal of depolarization. Phosphorylated cyclic adenosine
monophosphate response element-binding protein (pCREB), a nuclear transcription factor, was elevated after recovery from
depolarization-induced muting, consistent with a model in which PKA-dependent mechanisms, possibly including pCREB-
activated transcription, mediate slow unmuting. In summary, we found that protein synthesis was required for slower, PKA-
dependent unmuting of presynaptic terminals, but it was not required for muting or a fast form of unmuting. These results
clarify some of the molecular mechanisms responsible for synaptic plasticity in hippocampal neurons and emphasize the
multiple mechanisms by which presynaptic function is modulated.
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Introduction
Synapses are important sites for malleability of nervous system
function. The silencing, or muting, of presynaptic terminals is
arguably one of the least understood forms of synaptic malleability
[1]. Mute synapses represent a class of terminals that completely
fail to release transmitter in response to stimulation. Under basal
conditions, a small population of hippocampal glutamatergic
synapses is mute [2–5]. These silent terminals represent a reservoir
that can rapidly [6,7] or slowly [2,5,8–10] be activated for
participation in neurotransmission. Furthermore, the population
of basally active glutamatergic synapses can be muted selectively
by strong depolarization [4,11], including hypoxia-induced de-
polarization [[4,11,12], by inhibitory G-protein activation [13],
and by direct decreases in cyclic adenosine monophosphate
(cAMP) signaling [9]. Following a strong depolarizing challenge,
muted synapses return to their active state within 3–4 h through
a cAMP/PKA-dependent process [4,9].
The complete signaling cascades responsible for muting and
unmuting of hippocampal glutamatergic synapses remain unclear
[1]. For example, slower forms of unmuting occur through cAMP-
dependent signaling [5,8–10] while rapid unmuting can be
induced by phorbol esters [6]. These different time courses
implicate disparate signaling cascades in unmuting. Relatively slow
muting and unmuting could require protein synthesis or protein
degradation. Proteasome activity is required for muting [14],
suggesting a role for degradation. On the other hand, protein
synthesis is required for some forms of persistent synaptic
depression [15–17], so protein synthesis remains a plausible
contributor to muting. Protein synthesis is also required for
synaptic potentiation [18–20]; therefore, protein synthesis could
also contribute to unmuting.
The present work, therefore, investigates the role of protein
synthesis in presynaptic muting and unmuting in cultured
hippocampal glutamatergic neurons. We found that muting after
strong depolarization did not require protein synthesis. After
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depolarization was removed, the recovery of synaptic function and
levels of the candidate unmuting protein Rim1 required both
protein synthesis and PKA signaling. Levels of phosphorylated
nuclear transcription factor CREB were elevated during the
recovery period in a PKA-dependent manner, suggesting that
CREB could be one intermediary through which PKA directs
protein synthesis during the recovery period. Unmuting of basally
mute terminals by phorbol esters did not require protein synthesis,
however. We conclude, therefore, that protein synthesis is required
for PKA-dependent unmuting of presynaptic terminals in
glutamatergic hippocampal neurons, but muting of active




All procedures were carried out in accordance with the Guide for
the Care and Use of Laboratory Animals published by the United States
National Institutes of Health and were approved by the
Washington University School of Medicine Animal Studies
Committee. Primary hippocampal neuron cultures were prepared
as previously described [21]. Hippocampi were removed from
postnatal day 0–3 rat pups and incubated in 1 mg/ml papain.
Cells were mechanically dissociated and plated as either ‘‘mass’’
cultures (,650 cells/mm2 on a uniform layer of collagen) or
‘‘microisland’’ cultures (,25 cells/mm2 on stamped microdots of
collagen). Plating medium consisted of Eagle’s medium (Invitro-
gen) supplemented with heat-inactivated horse serum (5%), fetal
bovine serum (5%), 17 mM glucose, 400 mM glutamine, 50 mg/ml
streptomycin, and 50 U/ml penicillin. Cultures were maintained
at 37uC in a humidified incubator under controlled atmospheric
conditions (5% CO2/95% air). Cytosine arabinoside (6.7 mM) was
added at 3–4 days in vitro (DIV) after plating to inhibit cell division.
At d in vitro (DIV) 1 (mass cultures) or DIV 4–5 (microisland
cultures), a medium exchange was performed with Neurobasal
medium (Invitrogen) plus B27 supplement. All experiments were
conducted on neurons 10–14 DIV.
To depolarize neurons strongly during muting induction, we
added 30 mM KCl to the culture medium, which depolarizes the
membrane potential to -20 to -30 mV [22,23]. Ionotropic
glutamate receptor blockers D-APV (25–50 mM) and NBQX
(1 mM) were added to prevent toxicity and NMDA receptor-
dependent plasticity. Controls were sibling cultures that received
NaCl instead of KCl as a non-depolarizing osmotic control. For
recovery, cultures were switched to fresh co-culture-conditioned
medium or Neurobasal medium with B27 supplement for 3–4 h.
For cycloheximide, KT5720 (EMD Millipore), and actinomycin D
treatments, cultures were pretreated with each drug for 30–
120 min immediately prior to manipulations described in the
results. For cell death assays, cultures were treated with two doses
of 50 mM C6-ceramide 5 h apart in the absence or presence of
1 mM cycloheximide.
Electrophysiology
All electrophysiology experiments utilized microisland cultures.
Sibling cultures plated on the same day from the same litter were
always used to control for inter-plating variability. Whole-cell
recordings were performed using pClamp version 9 or 10 software
(Molecular Devices), an Axopatch 1D or Multiclamp 700B
amplifier (Molecular Devices), and a Digidata 1322 acquisition
board (Molecular Devices). Electrodes were 3–6 MV resistance,
and access resistance was compensated 85–100%. Before re-
cording, the culture medium was typically exchanged for
recording solution (pH = 7.25) containing the following: 138 mM
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose,
10 mM HEPES, and 25 mM D-APV. For conditions in which cells
were previously treated with cycloheximide, 5 mg/ml cyclohexi-
mide was sometimes added to the recording saline to prevent the
recurrence of protein synthesis during the recording session. Acute
applications of cycloheximide did not have any effect on autaptic
EPSC amplitudes (saline: -23.765.3 nA; saline+cycloheximide: -
23.865.3 nA; p= 0.57, Student’s paired t test). The whole-cell
pipette solution (pH = 7.25) contained the following: 140 mM K-
gluconate, 500 mM CaCl2, 5 mM EGTA, and 10 mM HEPES.
Neurons were stimulated by voltage pulses from270 mV to 0 mV
for 1.5 ms to evoke transmitter release and were recorded up to
1 h after switch to recording saline.
Immunoblotting
Immunoblotting was performed as previously described [14].
Briefly, cultured neurons from four mass cultures per condition
were separately collected for each experiment to account for
dish-to-dish variability in cell number. Each dish of neurons was
washed twice in phosphate-buffered saline (PBS) and lysed in 1x
reducing Laemmli’s sample buffer plus protease inhibitors
(10 mg/ml leupeptin and 20 mg/ml aprotinin). Samples from
these four dishes per condition were loaded into separate lanes
for separation. Individual samples were separated under reducing
conditions using 4–12% Bis-Tris or 3–8% Tris-acetate NuPAGE
gels (Invitrogen) and transferred to nitrocellulose. The blots were
then incubated in 3% non-fat dried milk (NFDM) dissolved in
20 mM Tris, 137 mM NaCl, and 0.1% Tween 20 at a pH of 7.6
(TTBS). Primary antibodies [Munc13–1 (Synaptic Systems) at
1:1000, Rim1 (BD Biosciences) at 1:1000] and horseradish
peroxidase-conjugated secondary antibodies were diluted in 1%
NFDM in TTBS. Lumigen-TMA6 (GE Healthcare) or Super-
Signal West Pico Chemiluminescent Substrate (Pierce) were used
to detect bands while the Kodak ImageStation 440CF was used
to capture the bands digitally. Densitometry was performed with
Kodak 1D Image Analysis software. After image capture, blots
were stripped using Restore Western Blot Stripping Buffer
(Pierce) and re-probed with tubulin antibody (1:4000) as a control
for total protein levels or with SV2 antibody (1:1000; De-
velopmental Studies Hybridoma Bank, University of Iowa) as
a control for presynaptic protein levels.
Immunocytochemistry and Fluorescent Imaging
For immunocytochemistry of vesicle priming proteins, mass
cultures were fixed in 4% paraformaldehyde/0.02% gluteralde-
hyde for 10 min before application of Rim1 (1:500) or Munc13–1
(1:500) primary antibody, typically combined with vesicular
glutamate transporter 1 (vGluT-1) primary antibody (Millipore
Corporation; 1:2000). Secondary antibody for Rim1 or Munc13–1
was Alexa 647-conjugated anti-mouse antibody at 1:500 dilution,
and vGluT-1 secondary antibody was Alexa 488-conjugated anti-
guinea pig antibody (1:500; Life Technologies). MAP2 (1:2000;
EMD Millipore), pCREB (1:400; EMB Millipore), CREB (1:300;
EMD Millipore), and GABA (1:500; Millipore Corporation)
primary antibodies were applied in some experiments after
10 min fixation in 4% paraformaldehyde/0.025–0.2% glutaral-
dehyde. Secondary antibodies were Alexa 488-conjugated anti-
guinea pig antibody (1:500; Life Technologies), Alexa 647-
conjugated anti-rabbit antibody (1:500; Life Technologies), and
Cy3-conjugated anti-mouse antibody (1:500; EMD Millipore), as
appropriate. Glass coverslips were mounted onto microscope slides
using Fluoromount-G (Southern Biotechnology).
Protein Synthesis in Synaptic Unmuting
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Dye loading of presynaptic terminals was performed as
previously described [24]. Briefly, fixable FM1-43 (FM1-43FX;
10 mM; Molecular Probes), 45 mM KCl, and 1 mM NBQX
(Tocris Biosciences) in extracellular recording saline were applied
for 2 min to mass cultures plated on glass coverslips. After ,5 s
rinse with 500 mM Advasep-7 (CyDex) in extracellular saline,
neurons were washed with extracellular saline for 10 min and then
fixed for 10 min in 4% paraformaldehyde/0.2% glutaraldehyde in
PBS. Cultures were washed 3X in PBS and incubated in blocking
solution (4% normal goat serum/0.04% Triton X-100 in PBS) for
15 min. vGluT-1 primary antibody was applied at 1:2000 for 3 hr.
After washing with PBS (3X), neurons were incubated in Alexa
647-conjugated anti-guinea pig antibody for 45 min (1:500;
Millipore Corporation), washed again in PBS (3X), and mounted
onto microscope slides.
Fluorescent images were acquired using a Nikon C1 scanning
confocal laser and 60x objective (1.4 numerical aperture) attached
to an inverted Eclipse TE2000 microscope (Nikon). Images were
acquired using EZ-C1 software (Nikon) by an observer naı¨ve to
experimental conditions. Representative fields were imaged in z-
stack using alternating excitation by 488 nm, 543 nm, and/or
633 nm laser lines as appropriate while gain settings, pixel dwell,
field of view size, and z-stack parameters were held constant
throughout an experiment. Monochrome images were converted
into 2D projected images for analysis using Metamorph Software
(Universal Imaging).
Data Analysis
All electrophysiology data were analyzed using Clampfit 9 or 10
(Molecular Devices) and Excel 2007 (Microsoft) software. At least
3 EPSCs were averaged and baseline-subtracted to measure
autaptic EPSC amplitudes from individual neurons. For cell death
assays, ten fields of neurons were counted with phase-contrast
optics and a 20x objective by an observer naı¨ve to conditions
before ceramide treatment and 24 h after treatment. Cell death
was quantified by calculating the percentage of cell loss after
treatment compared to before treatment in the same dish.
Confocal images were analyzed with Metamorph software by an
observer naı¨ve to the experimental conditions. For synaptic Rim1
and Munc13–1 quantification, regions were defined by vGluT-1
immunostaining, Rim1 or Munc13–1 integrated intensity was
measured, and the values for all measured Rim1 or Munc13–1
puncta within a field were averaged for 5 fields per experiment.
For pCREB and CREB experiments, average intensity was
measured from 100 pixel square regions placed within the
immunostained area. The percentage of active synapses was
quantified as the percentage of vGluT-1-defined regions contain-
ing at least 10 thresholded pixels in the FM1-43FX image for 5
fields per experiment, as described in [13]. Graphs were created
using SigmaPlot software (SPSS), and all quantifications are
presented in the text and figures as mean 6 SEM. Paired and
unpaired Student’s t tests, with Bonferroni correction for multiple
comparisons where appropriate, were used to determine if
statistically significant differences were present unless otherwise
stated (corrected p,0.05). For Rim1 immunostaining and Western
blot experiments, one-way ANOVA followed by Newman-Keuls
post hoc tests (p,0.05) were used.
Materials
All reagents are from Sigma unless otherwise indicated.
Results
Protein Synthesis is not Required for Depolarization-
induced Muting
Although many persistent forms of synaptic plasticity, in-
cluding long-term depression [15–17], require protein synthesis,
it is unknown whether protein synthesis plays a role in
presynaptic muting induction. To test this, we applied cyclohex-
imide (1–5 mg/ml), a rapidly reversible protein synthesis inhibitor
that blocks translation elongation, during our induction protocol
for presynaptic muting in hippocampal neurons. We focused on
Figure 1. Protein synthesis is not required for depolarization-
induced muting. A. Representative autaptic EPSCs from hippocampal
neurons after 16 h 30 mM NaCl (control) or 30 mM KCl (depolarized)
with or without 1 mg/ml cycloheximide 30 min pretreatment and co-
incubation (cyh). B. Summary of EPSC amplitudes from neurons treated
as in panel A (n= 10 neurons). *p,0.05, Bonferroni corrected Student’s
unpaired t test.
doi:10.1371/journal.pone.0051930.g001
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a prolonged, supraphysiological depolarization challenge (16 h;
[4]) to produce strong synaptic depression and to invoke any late-
phase components of depression most likely to require protein
synthesis. We used autaptic excitatory postsynaptic current
(EPSC) amplitudes to measure an estimate of presynaptic vesicle
release; postsynaptic receptor expression is unaltered by this
muting induction protocol while estimates of the readily releas-
able vesicle pool are strongly depressed [4,11]. Evoked EPSC
amplitudes were strongly depressed after 16 h depolarization
(Fig. 1), as seen previously [4]. Cycloheximide co-incubation,
however, did not alter the baseline EPSC amplitude or prevent
the decreased amplitude after depolarization (Fig. 1). As a positive
control for protein synthesis inhibition by cycloheximide, we
examined ceramide-induced apoptosis in hippocampal neurons.
Ceramide (2 doses of 50 mM) increased hippocampal neuron
death over a 24 h period (untreated: 2668% death; ceramide:
55610% death; p= 0.0008, Bonferroni corrected; n= 5). This
neuron loss was prevented by 1 mM cycloheximide (cyclohexi-
mide: 33610% death; cycloheximide+ceramide: 25610% death;
p= 0.74 before Bonferroni correction; n= 4). Taken together,
these data suggest that protein synthesis is not required for
depolarization-induced presynaptic muting.
Protein Synthesis is Required for Recovery from
Depolarization-induced Muting
Increased muting correlates with a proteasome-dependent
reduction in the levels of priming proteins Rim1 and Munc13–1
[14]. It is possible, therefore, that recovery from muting requires
synthesis of these proteins for presynaptic terminals to regain
function. Protein synthesis is required for PKA-dependent
unmuting of basally mute synapses [7,8], but unmuting of
pathophysiologically muted synapses has not been explored.
Recovery from synaptic depression triggered by strong, prolonged
depolarization requires 3–4 h [4]; therefore, recovery from muting
is slow enough to engage protein synthesis pathways.
To test the hypothesis that protein synthesis is required for
recovery from muting, we blocked protein synthesis with
cycloheximide during a 3 h recovery period following the 16 h
depolarization challenge. Cycloheximide prevented the recovery
of the EPSC amplitude from depolarization-induced muting
(Fig. 2A and 2B). When cycloheximide was removed for an
additional 3 hr, however, EPSC amplitudes recovered (Fig. 2C),
demonstrating that cycloheximide did not permanently alter
presynaptic function. This suggests that recovery from presynaptic
muting requires protein synthesis.
Because loss of vesicle priming proteins Rim1 and Munc13–1,
but not loss of other presynaptic proteins, is associated with muting
[14], recovery of Rim1 and Munc13–1 levels may be responsible
for recovery of presynaptic function. To test if protein levels
recover in parallel with functional recovery, we measured Rim1
and Munc13–1 levels after recovery with Western blot. Both
proteins decreased after depolarization but recovered to control
levels within 3 h of switch to fresh, non-depolarizing medium
(Fig. 3A–C). In the presence of cycloheximide, protein levels did
Figure 2. Protein synthesis is required for functional recovery from depolarization-induced muting. A. Representative autaptic EPSCs
from hippocampal neurons after 16 h 30 mM NaCl (control), 16 h 30 mM KCl (depolarized), or 16 h 30 mM KCl followed by 3 h recovery in fresh
medium with (recovered+cyh) or without (recovered) 1–5 mg/ml cycloheximide. Cycloheximide was applied 0.5–2 h prior to and during recovery. B.
Summary of EPSC amplitudes from neurons treated as in panel A (n=14 neurons). C. Representative autaptic EPSCs from hippocampal neurons after
16 h 30 mM NaCl (control), 16 h 30 mM KCl followed by 3 h recovery in fresh medium with 5 mg/ml cycloheximide (recovered+cyh), or 16 h 30 mM
KCl followed by 3 h recovery in fresh medium with 5 mg/ml cycloheximide followed by an additional 3 h recovery in fresh medium without
cycloheximide (recovered+cyh+recovery). D. Summary of autaptic EPSC amplitudes from neurons treated as in panel C (n= 25 neurons). *p,0.05,
Bonferroni corrected Student’s unpaired t test.
doi:10.1371/journal.pone.0051930.g002
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not recover (Fig. 3A–C). These results were confirmed by
measuring the integrated intensity of Rim1 immunostaining at
glutamatergic synapses. Immunofluorescence intensity of Rim1
puncta decreased after 16 h depolarization and recovered within
3 h of switch to fresh medium (Fig. 3D and 3E). Cycloheximide
prevented the recovery in Rim1 immunofluorescence intensity
(Fig. 3D and 3E), suggesting that Rim1 levels, like synaptic
function, fail to recover in the presence of protein synthesis
inhibitors. We also measured Munc13–1 immunofluorescence
intensity at glutamatergic synapses treated with cycloheximide
during the recovery period. As expected, Munc13–1 levels were
depressed after recovery from depolarization in the presence of
cycloheximide when compared to levels in non-depolarized cells
(70.266.9% of control; p = 0.02, Bonferroni corrected; n= 20
fields). As with synaptic function, further recovery in the absence
of cycloheximide restored Munc13–1 levels (118.569.7% of
control; p = 0.44 vs. control, p,0.001 vs. recovery+cycloheximide,
Bonferroni corrected; n= 20 fields). Together, these data suggest
that protein synthesis is important for the recovery of priming
protein levels after depolarization has ceased. These results also
support the previous observation that Rim1 and Munc13–1
presynaptic functions are linked with each other [25–27] and that
their levels, unlike those of other proteins, correlate with the
percentage of non-mute presynaptic terminals [14].
Figure 3. Synthesis is required for protein recovery from depolarization-induced muting. A. Western blot analysis of whole-cell lysates
from hippocampal mass cultures treated with 16 h 30 mM NaCl (control), 16 h 30 mM KCl (depolarized), or 16 h 30 mM KCl followed by 3 h recovery
in fresh medium with (recovered+cyh) or without (recovered) 1 mg/ml cycloheximide. Cycloheximide was applied 0.5 h prior to and during recovery.
B. Summary of Rim1 levels from Western blots as shown in A (n= 3). Rim1 protein levels for each condition were normalized to SV2 and control
treatment. C. Summary of Munc13–1 levels from Western blots as shown in A (n= 3). Munc13–1 protein levels for each condition were normalized to
SV2 and control treatment. D. Representative images of Rim1 immunostaining in mass cultures after treatments as described in panel A. Scale bar
represents 2 mm. E. Quantification of Rim1 immunostaining at vGluT-1-positive synapses (not shown; n=15 fields). Integrated intensity values were
normalized to the average control value for a given experiment. *p,0.05, Newman-Keuls post hoc test vs. control after one-way ANOVA.
doi:10.1371/journal.pone.0051930.g003
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PKA Signaling is Required for Recovery from
Depolarization-induced Muting
Previous results suggest that cAMP- and PKA-dependent
pathways modulate presynaptic muting and unmuting over the
course of hours [1,9,13]. Additionally, inhibition of PKA signaling
with KT5720 prevents recovery of presynaptic function after
muting-inducing depolarization has been removed [9]. It is
unclear, however, whether the recovery of priming protein levels
also requires PKA signaling. We measured Rim1 levels using
Western blot after 16 h depolarization followed by 3 h recovery in
the presence of 2 mM KT5720. Levels of Rim1 remained
depressed when cells were incubated in KT5720 during the
recovery period (Fig. 4), suggesting that PKA signaling is required
for recovery of Rim1 levels from muting.
Because both synaptic function [9] and protein levels (Fig. 4)
require PKA to recover, PKA-dependent synthesis of presynaptic
Figure 4. PKA signaling is required for recovery of Rim1 levels
after depolarization-induced muting. A. Western blot analysis of
whole-cell lysates from hippocampal mass cultures treated with 16 h
30 mM NaCl (control), 16 h 30 mM KCl (depolarized), or 16 h 30 mM
KCl followed by 3 h recovery in fresh medium with (recovered+KT5720)
or without (recovered) 2 mM KT5720. KT5720 was applied 0.5 h prior to
and during recovery. B. Summary of Rim1 levels from Western blots as
shown in A (n= 3). Rim1 protein levels for each condition were
normalized to SV2 and control treatment. *p,0.05, Newman-Keuls post
hoc test vs. control after one-way ANOVA.
doi:10.1371/journal.pone.0051930.g004
Figure 5. Transcription is required for functional recovery from
depolarization-induced muting. A. Representative autaptic EPSCs
from hippocampal neurons after 16 h 30 mM NaCl (control), 16 h
30 mM KCl (depolarized), or 16 h 30 mM KCl followed by 3 h recovery
Protein Synthesis in Synaptic Unmuting
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priming proteins may be necessary for the recovery of presynaptic
function after a depolarizing stimulus is removed. We hypothe-
sized that PKA signaling upregulates transcription during re-
covery. Consistent with a role for de novo transcription, rather than
local translation, we found that applying the transcription inhibitor
actinomycin D (200 ng/ml) during recovery also blocked func-
tional recovery from muting (Fig. 5A and 5B). Similarly, we found
that actinomycin D prevented recovery of Rim1 levels at
excitatory synapses, as measured with immunofluorescence
(Fig. 5C). These results suggest that transcription, and not just
translation, are required for recovery of presynaptic protein levels
and function.
If cAMP/PKA-dependent protein synthesis is responsible for
unmuting, we would expect markers of PKA-dependent protein
synthesis to correlate with the recovery from depolarization-
induced muting. As a proxy for cAMP/PKA-dependent protein
transcription, we measured levels of pCREB immunostaining in
the nuclei of glutamatergic neurons during strong depolarization
and during the recovery period after depolarization was removed
(Fig. 6A). pCREB average intensity levels were elevated through-
out depolarization and remained higher than in control-treated
neurons after 3 h recovery (Fig. 6B and 6C). We also examined
pCREB levels in neurons treated with 30 min 50 mM forskolin,
which stimulates adenylyl cyclase-dependent production of cAMP.
Forskolin-treated neurons clearly exceeded baseline levels of
pCREB, but pCREB levels were not as strong as in depolarized
neurons (Fig. 6B and 6C). KT5720 application during recovery
from depolarization prevented the increased pCREB levels, even
though non-depolarized neurons were unaffected by KT5720
(Fig. 6D). Levels of total nuclear CREB protein were also elevated
after depolarization (37.864.6% increase; p,0.001, Bonferroni
corrected; n= 125 neurons), potentially contributing to the de-
polarization-induced increase in pCREB; however, total CREB
levels after recovery with or without KT5720 were not signifi-
cantly different from the non-depolarized control condition
(recovered: 4.963.5% increase; recovered+KT5720:6.863.2%
increase; p.0.05, Bonferroni corrected; n= 125 neurons). This
pattern suggests that elevated PKA activity, rather than activity of
other kinases or changes in total protein levels, is responsible for
increased CREB phosphorylation during the recovery period.
Although we used nuclear pCREB accumulation solely as
a correlative marker of PKA activity, the increased pCREB in
recovering neurons provides a possible substrate for cAMP/PKA-
dependent transcriptional regulation of recovery and the correlat-
ed net protein level increases. These data alone do not exclude the
possibility that elevated PKA activity during depolarization sows
the seeds of recovery (Fig. 6C, D), but our previous work has
demonstrated that PKA inhibitors KT5720 and Rp-cAMPS
applied only during the recovery period prevent unmuting [9],
suggesting that PKA-dependent processes are recruited after
removal of depolarization. Together with the present results, this
strengthens the evidence that cAMP-dependent transcription and
subsequent protein translation after removal of depolarization are
important for unmuting glutamatergic presynaptic terminals.
in fresh medium with (recovered+act D) or without (recovered) 200 ng/
ml actinomycin D. Actinomycin D was applied 0.5 h prior to and during
recovery. B. Summary of EPSC amplitudes from neurons treated as in
panel A (n=32 neurons). C. Quantification of Rim1 immunostaining at
vGluT-1-positive synapses (not shown; n= 15 fields). Integrated intensity
values were normalized to the average control value for a given
experiment. *p,0.05, Bonferroni corrected Student’s one-tailed un-
paired t test.
doi:10.1371/journal.pone.0051930.g005
Figure 6. Nuclear phosphorylated CREB (pCREB) levels remain
elevated after recovery from depolarization-induced muting.
A. Merged image of pCREB (red), GABA (blue), and MAP2 (green)
immunofluorescence in a mass hippocampal culture. B. pCREB
immunostaining after the following treatments: 30 min DMSO (control),
30 min 50 mM forskolin (forskolin 30 min), 30 min 30 mM KCl
(depolarized 30 min), 16 h 30 mM KCl (depolarized O/N), or 16 h
30 mM KCl followed by 3 h in fresh medium (recovered). C.
Quantification of pCREB intensity in GABA-negative nuclei after
treatments as described in panel A (n=327–586 neurons). Intensity
Protein Synthesis in Synaptic Unmuting
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Basally Mute Synapses are Unmuted by Protein
Synthesis-dependent and –independent Mechanisms
A sizable proportion (,25–50%) of hippocampal glutamatergic
synapses are mute prior to experimental manipulations [3–5]. We
and others have previously shown that cAMP-dependent pathways
[5,7–10,28,29] and phorbol esters [6,9] unmute some of these
basally mute synapses. The time courses required for these two
unmuting treatments are remarkably different, with phorbol esters
unmuting synapses after a couple minutes of treatment and
forskolin application requiring minutes to hours. The faster effects
of phorbol esters suggest that phorbol ester-induced unmuting may
be independent of protein synthesis, so we compared the protein
synthesis dependence of each of these treatments. We used
presynaptic vesicle labeling with FM1-43FX dye rather than
autaptic EPSCs to determine whether terminals are unmuted to
avoid inadvertent intrusion of other presynaptic and postsynaptic
modifications from forskolin and phorbol ester treatment [30–35].
As expected, both 4 h of forskolin (50 mM) and 2 min of phorbol
12,13-dibutyrate (PDBu; 1 mM) increased the percentage of
glutamatergic terminals exhibiting FM1-43FX fluorescence after
brief stimulation, which indicates an increase in the fraction of
functional presynaptic terminals (Fig. 7). Cycloheximide co-
incubation, however, prevented forskolin-induced unmuting but
not phorbol ester-induced unmuting (Fig. 7). These results suggest
that multiple molecular pathways unmute hippocampal glutama-
tergic presynaptic terminals, and the slower, PKA-dependent
pathways require protein synthesis.
Discussion
Here we present evidence that protein synthesis is involved in
PKA-dependent unmuting of hippocampal glutamatergic pre-
synaptic terminals. Muting in response to strong depolarization
did not require protein synthesis. Recovery of synaptic function
and vesicle priming protein levels after termination of depolariza-
tion, however, was prevented by translation and transcription
inhibitors. PKA inhibition also hindered recovery of a candidate
protein mediator and prevented the elevation of pCREB levels
during the recovery period. Combined with our previous data
suggesting that PKA activity is necessary for functional recovery
[9], these results suggest that PKA-dependent protein synthesis
may be important for recovery from muting. Levels of priming
proteins Rim1 and Munc13–1 correlated with synaptic function,
suggesting that these proteins are important for synapses to remain
active. Unmuting of basally mute synapses by forskolin also
required protein synthesis, although unmuting by phorbol esters
did not. This suggests that unmuting via PKA-dependent path-
ways, whether recruited endogenously after removal of an
excitatory stimulus or induced pharmacologically in non-depolar-
ized cells, requires formation of new protein.
Many persistent forms of synaptic plasticity require protein
synthesis. For example, Hebbian late-phase long-term potentiation
in the hippocampus requires protein synthesis [36–38]. Similarly,
evidence suggests that protein synthesis contributes to hippocam-
pal long-term depression [36,39]. Homeostatic forms of plasticity,
like synaptic scaling of AMPA receptors during prolonged activity
deprivation or enhancement, also require the synthesis of new
protein [40–42]. Interestingly, many of these forms of plasticity are
mediated by postsynaptic receptor changes and require local,
dendritic translation into protein but not DNA transcription. In
contrast, presynaptic unmuting after the removal of depolarization
in our study required both transcription and translation, suggest-
ing that local protein synthesis does not play a strong role. This
clarifies ambiguity in previous work, which tested for a role of
translation, but not transcription, in PKA-dependent activation of
dormant neurotransmitter release sites [7,8]. Unmuting could
involve activation of the transcription factor CREB or other PKA-
dependent transcription mechanisms. In our study, CREB
phosphorylation was elevated during the recovery period in
a PKA-dependent manner. PKA-dependent CREB phosphoryla-
tion is involved in protein synthesis under many contexts [43–45],
so it is plausible that nuclear CREB links PKA activity to protein
synthesis during unmuting. Future work could explicitly test the
role of pCREB-dependent transcription, for example by inhibiting
CREB with dominant-negative genetic manipulations [46–50].
In this study, levels of the presynaptic proteins Rim1 and
Munc13–1 correlated with synaptic function. A causal role for
Rim1 and Munc13–1 degradation in muting has previously been
suggested [14]. In the current study, Rim1 and Munc13–1 levels
decreased after muting induction, returned to baseline during the
recovery period, and remained at low levels when neurons
recovered from depolarization in the presence of protein synthesis
or PKA inhibitors. Rim1 and its molecular partner Munc13–1 are
important for vesicle priming [25,51–54], which is consistent with
the priming deficit induced by muting [11,55,56]. Prior work
suggests that Rim1 and Munc13–1 levels are selectively decreased
during muting since levels of several other presynaptic proteins
remain stable during muting induction [14]. Rim1a overexpres-
sion prevents muting and preserves Munc13–1 levels [14], and
forskolin treatment that unmutes basally mute terminals increases
Rim1 protein [9]. Altogether, this suggests that Rim1, and
potentially Munc13–1, synthesis participates in PKA-dependent
unmuting.
Protein synthesis was not required for muting, but evidence
suggesting that proteasome activity is required for loss of Rim1
and Munc13–1 during muting further supports our hypothesis that
levels of these proteins mediate muting status [14]. Although
depolarization increased pCREB levels, suggesting that protein
transcription is recruited during muting induction, increased
proteasome activity caused by depolarization [14] may induce
protein degradation that overcomes protein synthesis and causes
a net decrease in protein levels. We hypothesize that return to
normal levels of proteasome activity after removal of depolariza-
tion unmasks effects of protein synthesis, allowing for a net
increase in protein levels during recovery. Rim1a is a PKA
substrate [57], however, so effects on synaptic function by
additional posttranslational modifications to Rim1a are not ruled
out by our studies.
Additional complexities are likely to cloud the simple hypothesis
that Rim1 and Munc13–1 levels explain muting and unmuting.
The strong synaptic phenotype with mild reductions in priming
protein levels is not straightforwardly consistent with genetic
deletion studies showing mild functional deficits. Homozygous null
Rim1 animals exhibit reduced, but not extinguished, synaptic
functionality [26,53], possibly suggesting a degree of redundancy
among Rim isoforms [58]. Munc13–1 and Munc13–2 double
knockouts, in contrast, exhibit negligible synaptic function [56,59],
values were normalized to the average control value for each
experiment. *p,0.05, Student’s unpaired t test vs. control after
Bonferroni correction. D. Quantification of pCREB intensity in GABA-
negative nuclei after 16 h 30 mM NaCl (control), 16 h 30 mM KCl
(depolarized O/N), or 16 h 30 mM KCl followed by 3 h recovery in fresh
medium with (recovered+KT) or without (recovered) 2 mM KT5720
(n=45–145 neurons). KT5720 was applied 0.5 h prior to and during
recovery. Intensity values were normalized to the average control value
for each experiment. *p,0.05, Bonferroni corrected Student’s unpaired
t test.
doi:10.1371/journal.pone.0051930.g006
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Figure 7. Unmuting of basally mute synapses by forskolin, but not PDBu, requires protein synthesis. A. Representative FM1-43FX
(green) and vGluT-1 (red) merged images after 4 h DMSO (control), 4 hr DMSO plus 1 mg/ml cycloheximide (cyh), 4 h 50 mM forskolin (FSK 4 h), 4 h
50 mM forskolin plus 1 mg/ml cycloheximide (FSK 4 h+cyh), 2 min 1 mM PDBu (PDBu 2 min), or 2 min 1 mM PDBu plus 1 mg/ml cycloheximide (PDBu
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suggesting that Munc13 levels may be more important than Rim1
levels in determining synaptic functional status. Because both
Rim1 and Munc13–1 levels correlate with the percentage of non-
mute synapses, loss of both proteins simultaneously could mediate
the muting phenotype. This does not, however, rule out other
protein mediators or mechanisms that could be playing a role.
Additionally, we are not aware of studies directly linking CREB
phosphorylation with Rim1 or Munc13–1 transcription, so other
PKA-dependent regulators besides CREB or other intermediate
regulators downstream of CREB may be activated during
unmuting. Future work should clarify the pathway responsible
for unmuting-associated protein synthesis.
Interestingly, unmuting was induced via both protein synthesis-
dependent and -independent mechanisms. Protein synthesis-de-
pendent unmuting from baseline or following depolarization-
induced muting both exhibited PKA dependence. Unmuting of
basally mute synapses by PDBu, which we found was protein
synthesis-independent, does not require PKC activity [6]. Phorbol
ester unmuting, therefore, likely depends on direct interactions
with Munc13–1 [6,60–62]. One obvious difference between PKA-
dependent and phorbol ester-dependent unmuting is the time scale
required. A mere 2 min of PDBu application unmutes basally
mute synapses, but 2 min of forskolin has shown no effect on the
number of mute terminals in prior studies [6]. To unmute
synapses, PKA-dependent pathways required hours, not minutes,
which can be explained by the involvement of transcription and
translation.
Some previous studies have shown slow cAMP- or PKA-
dependent awakening of basally dormant synapses [5,7–10,28,29],
but our study additionally clarifies mechanisms involved in
homeostatic unmuting after removal of an excitatory stimulus.
Although our work implies that unmuting of depolarization-muted
terminals and basally mute terminals utilize the same signaling
cascades, prior work in genetic models argues that the signaling
cascades are more complex. Neurons doubly deficient in adenylyl
cyclase 1 and 8 fail to recover from depolarization-induced
muting, attributable to the loss of adenylyl cyclase 8, but these
terminals are awakened with forskolin activation [9]. This suggests
that forskolin application recruits additional adenylyl cyclase
isoforms than are endogenously recruited during recovery from
muting. Therefore, some downstream effectors may be differen-
tially activated by forskolin unmuting and homeostatic unmuting.
Unmuting after removal of depolarization may be triggered by
sensitization of adenylyl cyclases by the prolonged inhibitory G-
protein signaling activated during muting [13,63], but other
pathways may be involved in other forms of unmuting. These
findings highlight the multiple mechanisms by which presynaptic
unmuting can be manipulated and open the door to many
questions about physiological roles of muting and unmuting. For
example, it is conceivable that slower forms of muting and
unmuting mediate homeostatic and Hebbian plasticity in response
to network activity while faster unmuting may meet the demands
of dynamic, moment-to-moment nervous system function.
In summary we have described a form of adaptive presynaptic
muting induced by strong depolarization that did not require
protein synthesis but that past work has shown depends on protein
degradation. Recovery from this muting required both protein
synthesis and PKA activity, suggesting that cAMP signaling
controls presynaptic protein levels and neurotransmitter release.
This slow form of unmuting contrasts with much faster unmuting
by phorbol esters and emphasizes the multiple mechanisms
controlling neurotransmission competency of presynaptic term-
inals. In addition, priming proteins Rim1 and Munc13–1 are
viable candidate downstream targets for these changes. Our results
contribute to our understanding of the downstream events
controlling presynaptic functional status; however, many upstream
signals in the cascade remain to be elucidated [1]. Because
presynaptic muting is endogenously neuroprotective in vitro [12],
clarifying the complete signaling cascades involved in muting and
unmuting could aid development of therapies for conditions
involving dysregulated glutamate signaling.
Acknowledgments
We thank Ann Benz for technical help with cell cultures and all laboratory
group members for discussion.
Author Contributions
Conceived and designed the experiments: DCC KLM SM. Performed the
experiments: DCC KLM AT XJ. Analyzed the data: DCC KLM AT XJ
SM. Wrote the paper: DCC KLM SM.
References
1. Crawford DC, Mennerick S (2012) Presynaptically Silent Synapses: Dormancy
and Awakening of Presynaptic Vesicle Release. Neuroscientist 18: 216–223.
2. Ninan I, Arancio O (2004) Presynaptic CaMKII is necessary for synaptic
plasticity in cultured hippocampal neurons. Neuron 42: 129–141.
3. Ting JT, Kelley BG, Lambert TJ, Cook DG, Sullivan JM (2007) Amyloid
precursor protein overexpression depresses excitatory transmission through both
presynaptic and postsynaptic mechanisms. Proc Natl Acad Sci U S A 104: 353–
358.
4. Moulder KL, Meeks JP, Shute AA, Hamilton CK, de Erausquin G, et al. (2004)
Plastic elimination of functional glutamate release sites by depolarization.
Neuron 42: 423–435.
5. Kohara K, Ogura A, Akagawa K, Yamaguchi K (2001) Increase in number of
functional release sites by cyclic AMP-dependent protein kinase in cultured
neurons isolated from hippocampal dentate gyrus. Neurosci Res 41: 79–88.
6. Chang CY, Jiang X, Moulder KL, Mennerick S (2010) Rapid activation of
dormant presynaptic terminals by phorbol esters. J Neurosci 30: 10048–10060.
7. Bolshakov VY, Golan H, Kandel ER, Siegelbaum SA (1997) Recruitment of
new sites of synaptic transmission during the cAMP-dependent late phase of
LTP at CA3–CA1 synapses in the hippocampus. Neuron 19: 635–651.
8. Ma L, Zablow L, Kandel ER, Siegelbaum SA (1999) Cyclic AMP induces
functional presynaptic boutons in hippocampal CA3–CA1 neuronal cultures.
Nat Neurosci 2: 24–30.
9. Moulder KL, Jiang X, Chang C, Taylor AA, Benz AM, et al. (2008) A specific
role for Ca2+-dependent adenylyl cyclases in recovery from adaptive presynaptic
silencing. J Neurosci 28: 5159–5168.
10. Tong G, Malenka RC, Nicoll RA (1996) Long-term potentiation in cultures of
single hippocampal granule cells: a presynaptic form of plasticity. Neuron 16:
1147–1157.
11. Moulder KL, Jiang X, Taylor AA, Olney JW, Mennerick S (2006) Physiological
activity depresses synaptic function through an effect on vesicle priming.
J Neurosci 26: 6618–6626.
12. Hogins J, Crawford DC, Jiang X, Mennerick S (2011) Presynaptic silencing is an
endogenous neuroprotectant during excitotoxic insults. Neurobiol Dis 43: 516–
525.
13. Crawford DC, Chang CY, Hyrc KL, Mennerick S (2011) Calcium-independent
inhibitory G-protein signaling induces persistent presynaptic muting of
hippocampal synapses. J Neurosci 31: 979–991.
2 min+cyh) treatment. Cycloheximide was applied 0.5 h prior to and during treatments. Scale bar represents 5 mm. B. Quantification of the
percentage of vGluT-1-defined synapses labeled with FM1-43FX (active synapses) after treatments described in panel A (n= 20 fields). *p,0.05,
Bonferroni corrected Student’s unpaired t test vs. control.
doi:10.1371/journal.pone.0051930.g007
Protein Synthesis in Synaptic Unmuting
PLOS ONE | www.plosone.org 10 December 2012 | Volume 7 | Issue 12 | e51930
14. Jiang X, Litkowski PE, Taylor AA, Lin Y, Snider BJ, et al. (2010) A role for the
ubiquitin-proteasome system in activity-dependent presynaptic silencing.
J Neurosci 30: 1798–1809.
15. Huber KM, Kayser MS, Bear MF (2000) Role for rapid dendritic protein
synthesis in hippocampal mGluR-dependent long-term depression. Science 288:
1254–1257.
16. Kauderer BS, Kandel ER (2000) Capture of a protein synthesis-dependent
component of long-term depression. Proc Natl Acad Sci U S A 97: 13342–
13347.
17. Manahan-Vaughan D, Kulla A, Frey JU (2000) Requirement of translation but
not transcription for the maintenance of long-term depression in the CA1 region
of freely moving rats. J Neurosci 20: 8572–8576.
18. Duffy C, Teyler TJ, Shashoua VE (1981) Long-term potentiation in the
hippocampal slice: evidence for stimulated secretion of newly synthesized
proteins. Science 212: 1148–1151.
19. Stanton PK, Sarvey JM (1984) Blockade of long-term potentiation in rat
hippocampal CA1 region by inhibitors of protein synthesis. J Neurosci 4: 3080–
3088.
20. Nguyen PV, Abel T, Kandel ER (1994) Requirement of a critical period of
transcription for induction of a late phase of LTP. Science 265: 1104–1107.
21. Mennerick S, Que J, Benz A, Zorumski CF (1995) Passive and synaptic
properties of hippocampal neurons grown in microcultures and in mass cultures.
J Neurophysiol 73: 320–332.
22. Moulder KL, Cormier RJ, Shute AA, Zorumski CF, Mennerick S (2003)
Homeostatic effects of depolarization on Ca2+ influx, synaptic signaling, and
survival. J Neurosci 23: 1825–1831.
23. Crawford DC, Moulder KL, Gereau RWt, Story GM, Mennerick S (2009)
Comparative effects of heterologous TRPV1 and TRPM8 expression in rat
hippocampal neurons. PLoS ONE 4: e8166.
24. Moulder KL, Jiang X, Taylor AA, Benz AM, Mennerick S (2010) Pre-
synaptically silent synapses studied with light microscopy. J Vis Exp 35: e1676.
25. Betz A, Thakur P, Junge HJ, Ashery U, Rhee JS, et al. (2001) Functional
interaction of the active zone proteins Munc13–1 and RIM1 in synaptic vesicle
priming. Neuron 30: 183–196.
26. Schoch S, Castillo PE, Jo T, Mukherjee K, Geppert M, et al. (2002) RIM1alpha
forms a protein scaffold for regulating neurotransmitter release at the active
zone. Nature 415: 321–326.
27. Andrews-Zwilling YS, Kawabe H, Reim K, Varoqueaux F, Brose N (2006)
Binding to Rab3A-interacting molecule RIM regulates the presynaptic re-
cruitment of Munc13–1 and ubMunc13–2. J Biol Chem 281: 19720–19731.
28. Chavis P, Mollard P, Bockaert J, Manzoni O (1998) Visualization of cyclic
AMP-regulated presynaptic activity at cerebellar granule cells. Neuron 20: 773–
781.
29. Dubinsky JM, Fischbach GD (1990) A role for cAMP in the development of
functional neuromuscular transmission. J Neurobiol 21: 414–426.
30. Seino S, Shibasaki T (2005) PKA-dependent and PKA-independent pathways
for cAMP-regulated exocytosis. Physiol Rev 85: 1303–1342.
31. Kaneko M, Takahashi T (2004) Presynaptic mechanism underlying cAMP-
dependent synaptic potentiation. J Neurosci 24: 5202–5208.
32. Sokolova IV, Lester HA, Davidson N (2006) Postsynaptic mechanisms are
essential for forskolin-induced potentiation of synaptic transmission.
J Neurophysiol 95: 2570–2579.
33. Stevens CF, Sullivan JM (1998) Regulation of the readily releasable vesicle pool
by protein kinase C. Neuron 21: 885–893.
34. Linden DJ, Connor JA (1991) Participation of postsynaptic PKC in cerebellar
long-term depression in culture. Science 254: 1656–1659.
35. Gerber G, Kangrga I, Ryu PD, Larew JS, Randic M (1989) Multiple effects of
phorbol esters in the rat spinal dorsal horn. J Neurosci 9: 3606–3617.
36. Pfeiffer BE, Huber KM (2006) Current advances in local protein synthesis and
synaptic plasticity. J Neurosci 26: 7147–7150.
37. Bramham CR (2008) Local protein synthesis, actin dynamics, and LTP
consolidation. Curr Opin Neurobiol 18: 524–531.
38. Sajikumar S, Navakkode S, Frey JU (2005) Protein synthesis-dependent long-
term functional plasticity: methods and techniques. Curr Opin Neurobiol 15:
607–613.
39. Waung MW, Huber KM (2009) Protein translation in synaptic plasticity:
mGluR-LTD, Fragile X. Curr Opin Neurobiol 19: 319–326.
40. Goold CP, Nicoll RA (2010) Single-cell optogenetic excitation drives
homeostatic synaptic depression. Neuron 68: 512–528.
41. Ju W, Morishita W, Tsui J, Gaietta G, Deerinck TJ, et al. (2004) Activity-
dependent regulation of dendritic synthesis and trafficking of AMPA receptors.
Nat Neurosci 7: 244–253.
42. Sutton MA, Ito HT, Cressy P, Kempf C, Woo JC, et al. (2006) Miniature
neurotransmission stabilizes synaptic function via tonic suppression of local
dendritic protein synthesis. Cell 125: 785–799.
43. Meinkoth JL, Alberts AS, Went W, Fantozzi D, Taylor SS, et al. (1993) Signal
transduction through the cAMP-dependent protein kinase. Mol Cell Biochem
127–128: 179–186.
44. Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription
factor activated by a diverse array of extracellular signals. Annu Rev Biochem
68: 821–861.
45. Sands WA, Palmer TM (2008) Regulating gene transcription in response to
cyclic AMP elevation. Cell Signal 20: 460–466.
46. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, et al. (1998) A dominant-
negative inhibitor of CREB reveals that it is a general mediator of stimulus-
dependent transcription of c-fos. Mol Cell Biol 18: 967–977.
47. Gonzalez GA, Montminy MR (1989) Cyclic AMP stimulates somatostatin gene
transcription by phosphorylation of CREB at serine 133. Cell 59: 675–680.
48. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD (1999) Mediation by
a CREB family transcription factor of NGF-dependent survival of sympathetic
neurons. Science 286: 2358–2361.
49. Pittenger C, Huang YY, Paletzki RF, Bourtchouladze R, Scanlin H, et al. (2002)
Reversible inhibition of CREB/ATF transcription factors in region CA1 of the
dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron
34: 447–462.
50. Jancic D, Lopez de Armentia M, Valor LM, Olivares R, Barco A (2009)
Inhibition of cAMP response element-binding protein reduces neuronal
excitability and plasticity, and triggers neurodegeneration. Cereb Cortex 19:
2535–2547.
51. Deng L, Kaeser PS, Xu W, Sudhof TC (2011) RIM proteins activate vesicle
priming by reversing autoinhibitory homodimerization of Munc13. Neuron 69:
317–331.
52. Khodthong C, Kabachinski G, James DJ, Martin TF (2011) Munc13 homology
domain-1 in CAPS/UNC31 mediates SNARE binding required for priming
vesicle exocytosis. Cell Metab 14: 254–263.
53. Koushika SP, Richmond JE, Hadwiger G, Weimer RM, Jorgensen EM, et al.
(2001) A post-docking role for active zone protein Rim. Nat Neurosci 4: 997–
1005.
54. Calakos N, Schoch S, Sudhof TC, Malenka RC (2004) Multiple roles for the
active zone protein RIM1alpha in late stages of neurotransmitter release.
Neuron 42: 889–896.
55. Augustin I, Rosenmund C, Sudhof TC, Brose N (1999) Munc13–1 is essential
for fusion competence of glutamatergic synaptic vesicles. Nature 400: 457–461.
56. Rosenmund C, Sigler A, Augustin I, Reim K, Brose N, et al. (2002) Differential
control of vesicle priming and short-term plasticity by Munc13 isoforms. Neuron
33: 411–424.
57. Lonart G, Schoch S, Kaeser PS, Larkin CJ, Sudhof TC, et al. (2003)
Phosphorylation of RIM1alpha by PKA triggers presynaptic long-term
potentiation at cerebellar parallel fiber synapses. Cell 115: 49–60.
58. Kaeser PS, Deng L, Fan M, Sudhof TC (2012) RIM genes differentially
contribute to organizing presynaptic release sites. Proc Natl Acad Sci U S A 109:
11830–11835.
59. Varoqueaux F, Sigler A, Rhee JS, Brose N, Enk C, et al. (2002) Total arrest of
spontaneous and evoked synaptic transmission but normal synaptogenesis in the
absence of Munc13–mediated vesicle priming. Proc Natl Acad Sci U S A 99:
9037–9042.
60. Betz A, Ashery U, Rickmann M, Augustin I, Neher E, et al. (1998) Munc13–1 is
a presynaptic phorbol ester receptor that enhances neurotransmitter release.
Neuron 21: 123–136.
61. Rhee JS, Betz A, Pyott S, Reim K, Varoqueaux F, et al. (2002) Beta phorbol
ester- and diacylglycerol-induced augmentation of transmitter release is
mediated by Munc13s and not by PKCs. Cell 108: 121–133.
62. Duncan RR, Betz A, Shipston MJ, Brose N, Chow RH (1999) Transient,
phorbol ester-induced DOC2-Munc13 interactions in vivo. J Biol Chem 274:
27347–27350.
63. Watts VJ, Neve KA (2005) Sensitization of adenylate cyclase by Galpha i/o-
coupled receptors. Pharmacol Ther 106: 405–421.
Protein Synthesis in Synaptic Unmuting
PLOS ONE | www.plosone.org 11 December 2012 | Volume 7 | Issue 12 | e51930
